MPLT and BMY Related Headlines

Go Back

Jul 27, 2026 02:29PM Raymond James on Bristol-Myers Squibb Co. (BMY): 'we do not view the ZEPHYR data as signaling a risk to Cobenfy across indications'

MPLT and BMY Related Press Releases

Go Back

MPLT and BMY Related SEC Filings

Go Back